- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
PAPi predictor of right ventricular failure after inferior myocardial infarction
The pulmonary artery pulsatility index (PAPi), calculated from the ratio of the pulmonary artery pulse pressure to right atrial pressure, is a predictor of right ventricular failure after inferior myocardial infarction and left ventricular assist device implantation. A recent study suggests that lower PAPi is associated with all-cause mortality, major adverse cardiac events, and heart failure hospitalizations across a large heterogeneous patient sample. The study findings were published online in the journal Circulation: Heart Failure on February 09, 2022.
Although prior studies have focused on specific advanced disease samples, the clinical implications of PAPi across a large diverse sample of individuals with a range of cardiopulmonary diseases remains unclear. Therefore, Dr Emily K. Zern and her team conducted a study to evaluate the association between PAPi and adverse outcomes across a heterogeneous population.
In this study, the researchers examined consecutive patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort. They included 8285 patients with median PAPi across quartiles 1.7, 2.8, 4.2, and 8.7, and followed them over a mean follow-up of 6.7±3.3 years. They used multivariable Cox models to examine the association between PAPi and all-cause mortality, major adverse cardiac events, and heart failure hospitalizations.
Key findings of the study:
♦ Upon analysis, the researchers found that the patients in the lowest PAPi quartile had a
- 60% greater risk of death compared with the highest quartile (multivariable-adjusted hazard ratio, 1.60 )
- Higher risk of major adverse cardiac events (hazard ratio, 1.80) and
- High heart failure hospitalizations (hazard ratio, 2.08)
♦ They also noted that the patients in quartiles 2 and 3 also had an increased risk of cardiovascular events compared with quartile 4.
The authors concluded, "Compared with the highest PAPi quartile, patients in PAPi quartiles 1 to 3 had a greater risk of all-cause mortality, major adverse cardiac events, and heart failure hospitalizations, with greatest risk observed in the lowest quartile."
They further added, "A low PAPi, even at values higher than previously reported, may serve an important role in identifying high-risk individuals across a broad spectrum of cardiovascular disease."
For further information:
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751